The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...
Progressive pulmonary fibrosis (PPF) is a life-threatening, progressive lung condition, causing a continuous decline in lung function.1,2 -- Affecting up to 100,000 people in the U.S. and up to 5.6 ...
India has the second-highest incidence of chronic obstructive pulmonary disease (CoPD) in the world, after China. What you need to know about CoPD and the cost of treatment for the chronic lung ...
I’M Dr Suraj Kukadia, known as Dr Sooj, an NHS GP who has seen how life-changing COPD can be. As the colder months set in, I ...
Major advancements in pulmonary fibrosis treatment and critical warnings regarding both indoor air quality and scientific ...
Soy Carmín on MSN
6 Critical Updates on Crown Princess Mette-Marits Health Journey
Life just threw another curveball at the Norwegian royals, and honestly, it’s a lot to process. Crown Princess Mette-Marit is ...
The FDA approved nerandomilast tablets for adults with progressive pulmonary fibrosis, according to an industry press release ...
Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...
The FDA today approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of progressive pulmonary fibrosis (PPF ...
Dailymotion on MSN
How many Australians have COPD and don't know?
Australians with a debilitating and sometimes deadly lung disease may be missing out on early detection and treatment, with ...
GMA Network on MSN
Marcos: 3rd Wednesday of June of every year is ‘National Pulmonary Rehabilitation Day’
President Ferdinand Marcos Jr. has designated the third Wednesday of June of each year as “National Pulmonary Rehabilitation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results